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Background: The Centers for Disease Control and Prevention recommends persons at 
high risk for HIV infection in the United States receive annual HIV testing to foster early HIV 
diagnosis and timely linkage to health care. Heterosexuals make up a significant proportion of 
incident HIV infections (>25%) but test for HIV less frequently than those in other risk catego-
ries. Yet factors that promote or impede annual HIV testing among heterosexuals are poorly 
understood. The present study examines individual/attitudinal-, social-, and structural-level 
factors associated with past-year HIV testing among heterosexuals at high risk for HIV.
Methods: Participants were African-American/Black and Hispanic heterosexual adults 
(N = 2307) residing in an urban area with both high poverty and HIV prevalence rates. 
Participants were recruited by respondent-driven sampling in 2012–2015 and completed 
a computerized structured assessment battery covering background factors, multi-level 
putative facilitators of HIV testing, and HIV testing history. Separate logistic regression 
analysis for males and females identified factors associated with past-year HIV testing.
results: Participants were mostly male (58%), African-American/Black (75%), and 
39 years old on average (SD = 12.06 years). Lifetime homelessness (54%) and incarcer-
ation (62%) were common. Half reported past-year HIV testing (50%) and 37% engaged 
in regular, annual HIV testing. Facilitators of HIV testing common to both genders included 
sexually transmitted infection (STI) testing or STI diagnosis, peer norms supporting HIV 
testing, and HIV testing access. Among women, access to general medical care and 
extreme poverty further predicted HIV testing, while recent drug use reduced the odds 
of past-year HIV testing. Among men, past-year HIV testing was also associated with 
lifetime incarceration and substance use treatment.
conclusion: The present study identified gaps in rates of HIV testing among hetero-
sexuals at high risk for HIV, and both common and gender-specific facilitators of HIV 
testing. Findings suggest a number of avenues for increasing HIV testing rates, including 
increasing the number and types of settings offering high-quality HIV testing; promoting 
STI as well as HIV testing; better integrating STI and HIV testing systems; implementing 
peer-driven social/behavioral intervention approaches to harness the positive influence of 
social networks and reduce unfavorable shared peer norms; and specialized approaches 
for women who use drugs.
Keywords: hiV testing, hiV screening, heterosexuals, barriers to hiV testing, structural barriers, health disparities, 
sex differences
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inTrODUcTiOn
Since 2006, the Centers for Disease Control and Prevention 
(CDC) has recommended persons at high risk for HIV infection 
in the United States (US) receive diagnostic HIV testing annu-
ally, to foster early HIV diagnosis, timely linkage to HIV care, 
and modification of behaviors that potentially place others at 
risk for contracting HIV (1). In response, rates of lifetime HIV 
testing in the US have increased modestly, although fewer than 
half in the general population (44%) has ever been tested for HIV 
(2). African-Americans/Blacks have the highest rates of lifetime 
HIV testing (63.9%), followed by Non-Hispanic Whites (42.9%), 
then Mexican Americans (35.7%) (2). Further, those with a 
non-heterosexual identity (that is, lesbian, gay, bisexual, or other 
non-heterosexual identity) have higher lifetime HIV testing rates 
than heterosexuals (57.3 vs. 44.2%) (2). Yet heterosexuals make up 
a significant proportion of new HIV infections in the US (27%) 
(3) and the promotion of HIV testing among heterosexuals, 
particularly those at high risk for HIV infection, is a public health 
priority (1).
The factors that promote or impede HIV testing among 
high-risk heterosexuals are under-studied compared to other 
risk groups such as men who have sex with men (MSM) and 
persons who inject drugs (4, 5). A primary barrier to the study 
of heterosexuals at high risk (HHR) has been the lack of an 
accepted definition of the population (6, 7). The CDC National 
HIV Behavioral Surveillance (NHBS) system defines HHR for 
HIV as persons linked within urban geographical areas with 
elevated rates of heterosexually transmitted HIV, which also have 
very high rates of poverty (8). Further, African-American/Black 
and Hispanic populations are greatly over-represented in these 
“high-risk areas” compared to Whites (9). Yet rates of annual 
HIV testing are low among HHR: in New York City, only 31% 
of men and 35% of women had tested in the past year, although 
more than 90% had encountered settings where HIV testing 
was offered. This pattern suggests HHR frequently decline HIV 
testing, and, therefore, that access to high-quality services that 
motivate HHR to engage in HIV testing are lacking (10). As a 
result of these low HIV test rates, late diagnosis of HIV infection 
is common in this group (11–13). In response, the CDC has called 
for research to identify barriers to HIV testing for HHR, in order 
to inform future policies, culturally appropriate interventions, 
and HIV testing initiatives (14).
The present study explores a set of putative barriers to/facili-
tators of past-year HIV testing among African-American/Black 
and Hispanic HHR in New York City. Grounded in the literature 
which highlights the multiple factors that explain HIV testing in 
high-risk populations (15, 16), we conceptualize these potential 
factors within the Theory of Triadic Influence (17). The Theory of 
Triadic Influence is an integrative social-cognitive theory empha-
sizing three “streams of influence” on health behavior, namely at 
the individual/attitudinal-, social-, and structural levels, the latter 
receiving relatively little attention to date in the literature on HIV 
testing (18). Within the framework of this theory, the primary 
specific factors believed to influence the HIV testing behavior of 
HHR are summarized briefly below and described in more detail 
elsewhere (19).
Individual/attitudinal barriers to annual HIV testing include 
lack of awareness of recommended HIV testing frequency, low 
perceived risk of HIV (20), fear of HIV and its consequences 
including stigma (21, 22), and distrust of medical environments 
(21). Further, substance use serves as a barrier to HIV testing 
(21, 23), as do other “competing priorities,” such as mental 
health problems and unstable housing, complicated by low 
socioeconomic status (20, 24). At the social level of influence, 
insufficient social support (25) and perceived peer norms that 
do not support HIV testing can impede HIV testing (26). At the 
structural level of influence, HHR often have inadequate access 
to settings where high-quality HIV testing is offered (10, 13). 
Theoretically, barriers at these three levels of influence combine 
and interact to impede access to and motivation for HIV testing 
among HHR. At the same time, HHR evidence factors facilitating 
HIV testing, such as intrinsic motivation to achieve good health, 
and involvement in health-care and other settings that provide 
services (10, 27). Yet men and women differ in their need for and/
or access to health-care settings, for example, related to higher 
rates of incarceration among men, and receipt of gynecological 
and prenatal care for many women (10), suggesting the need to 
explore gender differences. The present study seeks to advance 
the literature on factors impeding or promoting past-year HIV 
testing in a population at-risk by examining barriers at multiple 
levels of influence, including structural-level factors, and explor-
ing gender differences.
MaTerials anD MeThODs
Design
Participants were recruited in 2012–2015 using respondent-
driven sampling (RDS) (28, 29), a peer-to-peer social network-
based recruitment method, as part of a larger study to test 
intervention approaches to uncover undiagnosed HIV infection 
among HHR in New York City. The study was approved by the 
Institutional Review Board of the New York University Langone 
School of Medicine.
study setting
Study procedures were modeled on the NHBS system with HHR 
(8) and were described in detail elsewhere (19). The study was 
located in a high-risk area (HRA) defined within Brooklyn, the 
borough in New York City with the highest heterosexual HIV 
prevalence at the time the study was planned (19). The HRA for 
the present study comprised two regions: a core area made up of 
the top 25% of zip codes ranked by heterosexual HIV prevalence 
and household poverty (seven zip codes, see the light gray area 
in Figure 1). Further, because the social networks of HHR cross 
zip code boundaries, the HRA also included the next quartile 
of zip codes (dark gray area in Figure  1). This was intended 
to maintain the study’s focus on this core HRA while reduc-
ing artificial restriction of RDS recruitment chains. The study 
field site was located in the core HRA, as was recruitment of 
the initial participants who started the RDS recruitment chains. 
However, recruitment of peers during RDS could extend to the 
larger HRA.
FigUre 1 | core high-risk area (“hra,” in light gray) and surrounding 
larger hra, in the borough of Brooklyn in new York city.
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sampling and recruitment
RDS is designed to reach deep into hidden or wary popula-
tions, engaging more isolated network members who may not 
be present or easy to engage in typical social venues (30). RDS 
begins with recruitment of “initial seeds,” who then recruit a 
small number of their peers for the study. Next, peer-to-peer 
recruitment continues until sample size goals are met. Each 
set of peers recruited is called a “recruitment wave.” In the 
present study, a total of 107 initial seeds, selected to vary in age, 
gender, race/ethnicity, and substance use history, were directly 
recruited by staff in 2012–2014 from public and street venues 
within a core HRA, and enrolled into the study. Each seed could 
start a recruitment chain by recruiting three to five of their 
peers (47% of initial seeds recruited ≥1 peer), and these peers 
then entered the study and recruited their own peers until the 
target sample size was achieved. The average number of waves 
on these recruitment chains was 7 (range 1–26 waves/chain). 
Overall 66% of participants (including both initial seeds and 
peers) recruited at least one individual. Both seeds and peers 
are included as participants in the present study, but some 
participants were excluded if they were screened for the study 
prior to a change made in inclusion criteria related to HIV 
testing history (n =  383) described in more detail elsewhere 
(19) or were missing data on variables needed for analysis 
(n = 304). Thus, the sample size for the present study was 2307 
participants.
eligibility
Study eligibility criteria for the initial seeds were 18–60  years; 
sexually active (vaginal and/or anal sex) with at least one opposite 
sex partner within the previous year; reside in the core HRA in 
central Brooklyn; African-American/Black or Hispanic race/
ethnicity (to focus on the populations with the greatest barriers 
to regular HIV testing); comprehension of English or Spanish; 
unknown or negative HIV status; and not actively psychotic based 
on a standard screening instrument (31, 32). Eligibility criteria 
for peers were the same with two exceptions: peers could reside in 
the core or larger HRA (to reduce artificial restriction on recruit-
ment chains), and peers could have an HIV-negative, unknown, 
or HIV-positive status (because HIV-infected individuals can be 
a conduit to those with undiagnosed HIV infection, but including 
HIV-infected individuals as initial seeds could potentially lead to 
an over-presentation of HIV-infected participants in the study). 
The present paper excludes those enrolled who were previously 
diagnosed with HIV (N = 116).
Procedures and Measures
Enrollment and Assessment
With the exception of initial seeds, participants were recruited 
by peers and presented to the study field site with a coded 
recruitment coupon linking them back to the recruiter. Potential 
participants, both initial seeds and peers, provided verbal consent 
and were screened for eligibility with a brief structured assess-
ment (10 min). Those found eligible provided signed informed 
consent for remaining study activities and then completed a 
structured baseline interview. The interview lasted 60–90  min 
and was administered by trained staff on computers using an 
audio, computer-assisted self-interviewing (ACASI) program 
(33). Participants received compensation of $15 for the screening 
and $30 for the baseline interview, as well as funds for round-trip 
local transportation. The recruiter received $15 for each peer 
referred and found eligible.
Measures
The measures used in the present study were drawn primarily 
from a set of harmonized instruments used for the set of “Seek, 
Test, Treat, and Retain” studies sponsored by the National Institute 
on Drug Abuse (NIDA) at the National Institutes of Health (34). 
These measures have been used in past studies with HHR and 
similar vulnerable populations and are described in brief below 
(Cronbach’s alpha provided for scales where appropriate).
Sociodemographic and Background Factors and Barriers 
and Facilitators
Sociodemographic and Background Factors. Using a structured 
NIDA-harmonized instrument (35), we assessed age (in years), 
race/ethnicity (African-American/Black and Latino/Hispanic), 
and gender (coded as male gender, yes/no). The remaining socio-
demographic indices were coded to reflect the predominant cat-
egories and were coded as yes/no, with the “yes” value presented 
in the tables below for parsimony. These included marital status 
(married or living as married or in a long-term relationship), 
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whether has children and whether children <10 years old live at 
home, heterosexual identity (because some participants met eligi-
bility criteria and identified as bisexual), education level, namely, 
whether the participant has achieved a high-school (HS) diploma 
or completed HS or a General Educational Development (GED) 
test but no college, employed full or part-time, financial insecu-
rity (i.e., unable to pay for necessities in the past year), any health 
insurance, housing status (that is, whether has ever been home-
less and is currently homeless), and history of incarceration (ever 
incarcerated and if so, whether incarcerated in the past year).
Sexual Behavior and Involvement in Sex Work. The NHBS mea-
sure (36) was used to gather data on lifetime and past month sex-
ual behavior and history, coded as yes/no or presented as a mean 
and standard deviation SD. These included whether participants 
had a same sex partner over their lives (yes/no), engaged in a 
group sex event over the lifetime (yes/no), the number of sex-
ual partners past month (mean, SD), whether had sex without 
a condom past month (yes/no), and whether, over the lifetime, 
engaged in transactional sex such as giving money/drugs to and/
or receiving money/drugs from a partner in exchange for sex.
Drug and Alcohol Use. Using NIDA-harmonized instruments 
(37), we assessed drug use in the past year (yes/no) and past 
month (yes/no) across 12 different substances, the frequency of 
drug use in the past month on an 8-point Likert-type scale rang-
ing from never through 10 or more times a day/almost every day 
(mean, SD) (38). Using recognized screening measures (TCU 
Drug Screen and AUDIT) and established cut-off values for 
problematic levels of use, we assessed the presence or absence 
of drug use problems in the past year [nine items; Cronbach’s 
alpha (α) =  0.91] (39); as well as alcohol problems in the past 
year (10 items; α = 0.89) (40), coded as problematic drug or alco-
hol use (yes/no), and the proportion who experienced either a 
drug or alcohol problem in the past year. Substance use treatment 
over the lifetime, an indication of substance use problems, was 
assessed (e.g., detoxification, rehabilitation, outpatient treatment, 
and 12-step programs) and coded as present or absent across all 
categories. Daily cigarette smoking was assessed, as was lifetime 
and past-month history of injection drug use (37).
Physical and Mental Health. We assessed general health using 
the RAND-36 (five items, α =  0.77; range 0–100, with higher 
scores indicating better perceived health) (41); a history of sexu-
ally transmitted infection (STI) testing (other than HIV testing) 
and STI diagnosis over the lifetime (38); depressive symptoms 
at a clinically significant level over the past week (20-item CES-
D; α = 0.80) (42); and current general anxiety at a clinically sig-
nificant level (six-item BSI anxiety; α =  0.88) (43). Composite 
depression and anxiety scores were calculated and cut-offs of 16 
or greater (depression) and 0.7 or greater (anxiety) were used to 
determine presence or absence of symptoms at a clinically sig-
nificant level.
Individual/Attitudinal-Level Factors. HIV knowledge was 
assessed with the HIV-KQ-18 (18 true/false items; α = 0.81, e.g., 
“People who have been infected with HIV quickly show serious 
signs of being infected”) (44); distrust of health care (seven items; 
assessed on a 5-point Likert-type scale; α = 0.72, e.g., “Sometimes 
I wonder if healthcare organizations really know what they are 
doing”) (45); and HIV fears and conspiracy beliefs (five items; 
α = 0.69, assessed on a 5-point Likert-type scale; e.g., “There is 
a cure for HIV or AIDS but the government is keeping it from 
us”) (46). For each scale, after re-coding reverse-coded items as 
appropriate, items were summed (knowledge) or averaged (dis-
trust and fears/conspiracy beliefs) to provide scale scores, and a 
mean and SD calculated. We assessed health literacy (one item, 
“How confident are you filling out medical forms by yourself?” 
where participants with less confidence were contrasted with 
extremely confident participants) (47).
Social-Level Factors
We assessed social support (five items; assessed on a 5-point 
Likert-type scale; α = 0.88, e.g., “extent to which you have some-
one to love and make you feel wanted?”) (41); and perceived 
peer norms in support of HIV testing (seven items; assessed on 
a 7-point Likert-type scale and reverse-coded as appropriate; 
α = 0.64; including descriptive norms, that is, an individual’s per-
ceptions of what other people are doing; e.g., “How many of your 
close friends and family have ever had an HIV test?,” and injunc-
tive or proscriptive norms, that is, perceptions of what behaviors 
other people consider acceptable; e.g., “How many of your close 
friends and family have encouraged you to get an HIV test?”) 
(48). For both of these scales, after re-coding reverse-coded items 
as appropriate, items were averaged.
Structural-Level Factors
We assessed ability to access general medical care when needed 
as a single item (yes/no) (49); overall barriers to general medical 
care (10 items; coded yes/no; α = 0.79, e.g., not sure where to go 
to get medical care, did not have transportation to medical care; 
summed with a range of 0–10) (50); and perceived ease of access 
to HIV testing, a scale that included organizational factors, such 
as ease of access, convenience, professionalism, and confidential-
ity, as well as emotional/attitudinal barriers that impede access, 
such as fatalism and fear and mistrust of HIV testing (14 items; 
assessed on a 5-point Likert-type scale α = 0.81; averaged, result-
ing in a range of 0–4) (50).
Data Analysis
Logistic regression was used to estimate bivariate associations 
between predictors and HIV testing in the past year separately 
for women and men. Logistic regression was also used to estimate 
associations in multivariable models separately for women and 
men. Multivariable models started with main effects of 47 potential 
predictors of HIV testing in the past year (all variables in Table 1 
except for gender and recent HIV testing). Starting with terms 
furthest from significance, terms were removed if the associated 
p-value (p) was greater than 0.10. This backward elimination of 
non-significant terms used the method of Lawless and Singhal 
(51) implemented in the rms package (52) of the R statistical 
computing environment (53), which was used for all analyses.
TaBle 1 | Participant characteristics.
% or mean (sD)
sociodemographic and background factors
HIV test in the past year 50.41
Male gender 57.56
Age (years) 39.10 (12.06)
African-American/Black 73.95
Latino/Hispanic 23.93
Married, living as married 21.72
In a long-term relationship 34.72
Has any children 67.71
Children <10 living at home 20.03
Identifies as heterosexual 88.21
No high school diploma 35.98
Completed HS or GED but no college 41.09
Employed full or part-time 19.38
Ran out of money for basic necessities past 12 months 80.84
Any health insurance 85.52
Ever homeless 54.49
Currently homeless 21.37
Ever incarcerated 61.94
Past year incarceration if ever incarcerated 23.02
sexual behavior and involvement in sex work
Lifetime same sex partner(s) 18.73
Lifetime group sex 18.16
Number of sex partners past month 1.72 (3.92)
Sex without a condom past month 59.56
Lifetime gave money/drugs for sex 23.49
Lifetime received money/drugs for sex 31.04
Drug and alcohol use and problems
Any drug use in the past year 46.03
Any drug use in the past month 32.77
Drug use frequency past month (0–8) 1.34 (2.38)
Meets TCU criterion for drug problem past year 21.15
Meets AUDIT criterion for alcohol problem past year 25.88
Meets criterion for drug or alcohol problem past year 36.93
Ever in substance use treatment 42.78
Daily cigarette smoking in the past month 53.97
Ever injected drugs not for a medical reason 9.06
Injected drugs in the past 30 days 1.30
Physical and mental health
RAND-36 general health 70.12 (19.75)
STI testing lifetime 66.67
STI diagnosis lifetime 25.88
CESD-20 depression total score ≥16 57.48
BSI anxiety ≥0.70 57.65
individual/attitudinal-level factors
HIV knowledge (range 0–18) 12.67 (3.66)
Mistrust of health care (range 0–4) 2.02 (0.69)
HIV conspiracy beliefs (range 0–4) 1.47 (0.46)
Low health literacy 51.97
social-level factors
Social support (range 0–4) 2.21 (1.14)
Peer norms in support of HIV testing (range 0–6) 4.55 (0.95)
structural-level factors
Able to get medical care whenever needed 49.59
Barriers to care total (range 0–10) 1.51 (2.07)
HIV testing access (range 0–4) 3.41 (0.56)
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resUlTs
Participant characteristics
Table 1 shows sociodemographic and background factors, sexual 
behavior, drug and alcohol use and problems, physical and men-
tal health, individual-attitudinal factors, social-level factors, and 
structural-level factors. About 58% of participants were male, 
and most (75%) were non-Hispanic African-Americans/Blacks. 
Age ranged from 18 to 60 years, with a mean age of 39.10 years 
(SD = 12.06 years). Many (36%) had not completed HS or attained 
a GED, and more than half (54%) had experienced homelessness. 
More than half (62%) had been incarcerated, 23% within the past 
year. More than half (60%) had sex without a condom in the past 
month, and more than a quarter (28%) had more than one sex 
partner in the past month. Receiving money or drugs for sex 
was not uncommon (30%). About one in five participants (21%) 
met criteria for a current drug problem, and 37% met criteria 
for a current alcohol or drug problem. Many (43%) had received 
substance use treatment in the past. Over half (57%) had depres-
sive symptoms at a clinically significant level, as well as anxiety 
(58%), and most (72%) met criteria for either a current anxiety or 
depression problem (not in Table 1). Although most (86%) had 
health insurance, half (50%) reported they could not get medical 
care whenever they needed it.
Half reported testing for HIV within the past year (50%), 
although most had tested for HIV at least once prior to the study 
(93%). To assess regularity of HIV testing since CDC’s annual 
HIV testing recommendation, we calculated the ratio of number 
of lifetime HIV tests to number of years in which the participant 
was at least 18 years of age. This ratio ranged from 0 to 56, with 
a median of 0.74. Thus, most participants (63%) reported fewer 
HIV tests than the number of years since the annual HIV testing 
recommendation began, indicating only 37% engaged in regular, 
annual HIV testing.
Predictors of hiV Testing in the Past Year
Table  2 shows bivariate associations between testing for HIV 
in the past year and other variables, by gender. Among women, 
older age [odds ratio (OR) = 0.82], drug use in the past month 
(OR = 0.74), drug use frequency in the past month (OR = 0.85), 
having elevated anxiety (OR  =  0.73), HIV conspiracy beliefs 
(OR = 0.82), low health literacy (OR = 0.59), and barriers to care 
(OR = 0.84) were each negatively associated with HIV testing in 
the past year (p < 0.05). Also among women, young children at 
home (OR = 1.35), health insurance (OR = 1.99), lifetime home-
lessness (OR = 1.44), better general health (OR = 1.15), lifetime 
STI testing (OR = 2.56), more knowledge of HIV (OR = 1.40), 
social support (OR = 1.24), peer norms in support of HIV testing 
(OR = 1.43), better access to medical care (OR = 1.87), and better 
access to HIV testing (OR = 1.75) were positively associated with 
HIV testing in the past year (p < 0.05).
Among men, low health literacy (OR = 0.74) was negatively 
associated with HIV testing in the past year (p <  0.05). Also 
among men, health insurance (OR = 1.41), lifetime or past year 
homelessness (OR = 1.44), past-year incarceration (OR = 1.57), 
meeting criteria for a drug or alcohol problem (OR =  1.31), 
lifetime substance use treatment (OR  =  1.51), daily cigarette 
smoking (OR = 1.28), lifetime STI testing (OR = 2.16), and more 
knowledge of HIV (OR = 1.27) were each positively associated 
with HIV testing in the past year (p < 0.05).
TaBle 2 | Factors associated with recent hiV testing among female and male heterosexuals at high risk in new York city (n = 2307).
Female (n = 979) Male (n = 1328)
no recent hiV  
test (n = 440)
hiV test in past 
12 months (n = 539)
Female bivariate 
odds ratio
no recent hiV  
test (n = 704)
hiV test in past 
12 months (n = 624)
Male bivariate 
odds ratio
Mean (sD) or % Mean (sD) or % Mean (sD) or % Mean (sD) or %
sociodemographic and background factors
Agea 39.65 (12.13) 36.42 (11.81) 0.82** 40.07 (12.41) 39.94 (11.52) 1.03
Children <10 living at home 27.05 36.36 1.35* 11.79 10.26 0.80
Any health insurance 87.27 93.14 1.99** 79.40 84.62 1.41*
Ever homeless 49.32 56.22 1.44** 51.28 60.26 1.44**
Currently homeless 17.05 19.67 1.25 20.45 26.92 1.50**
Past year incarceration 11.82 13.36 1.42 27.13 34.62 1.57***
sexual behavior and involvement in sex work
Lifetime same sex partner(s) 36.14 32.10 0.83 7.53 7.53 1.05
Lifetime group sex 15.68 15.58 0.98 18.89 21.31 1.10
Number of sex partners past montha 1.66 (3.56) 1.29 (2.04) 0.86 2.06 (4.04) 1.74 (2.96) 0.92
Sex without a condom past month 61.36 64.56 1.07 55.97 58.01 0.98
Lifetime gave money/drugs for sex 8.41 4.64 0.59 36.93 35.26 0.95
Lifetime received money/drugs for sex 27.73 26.90 1.07 31.82 36.06 1.25
Drug and alcohol use and problems
Any drug use in the past month 31.14 23.93 0.74* 39.49 33.97 0.79
Drug use frequency past month (0–8)a 1.23 (2.32) 0.89 (2.01) 0.85* 1.68 (2.57) 1.42 (2.42) 0.91
Meets criterion for drug or alcohol problem 35.00 32.47 0.99 36.93 42.15 1.31*
Ever in substance use treatment 31.59 31.73 1.09 47.16 55.29 1.51***
Daily cigarette smoking in the past month 49.09 50.83 1.11 54.12 59.94 1.28*
Ever injected drugs not for a medical reason 7.05 5.01 0.75 10.94 11.86 1.14
Physical and mental health (general, sti)
RAND-36 general healtha 68.03 (20.44) 71.55 (19.81) 1.15* 69.36 (19.63) 71.20 (19.20) 1.07
STI testing lifetime 69.32 85.34 2.56*** 49.86 67.63 2.16***
CESD-20 depression total score ≥16 61.36 57.33 0.92 55.97 56.57 1.01
BSI anxiety ≥0.70 60.23 50.65 0.73* 59.94 59.29 0.95
individual/attitudinal-level factors
HIV knowledge (0–18)a 12.23 (3.68) 13.48 (3.12) 1.40*** 12.02 (3.96) 13.00 (3.55) 1.27***
Mistrust of health care (0–4)a 2.04 (0.69) 1.98 (0.67) 0.93 2.02 (0.72) 2.05 (0.66) 1.07
HIV conspiracy beliefs (0–4)a 1.43 (0.76) 1.30 (0.69) 0.82** 1.56 (0.80) 1.53 (0.75) 0.99
Low health literacy 52.27 37.11 0.59*** 61.51 53.85 0.74*
social-level factors
Social support (0–4)a 2.19 (1.14) 2.49 (1.12) 1.24** 2.09 (1.14) 2.12 (1.12) 1.05
Peer norms about HIV testing (0–6)a 4.46 (1.01) 4.82 (0.86) 1.43*** 4.32 (0.99) 4.64 (0.88) 1.42***
structural-level factors
Able to get medical care whenever needed 49.77 65.49 1.87*** 39.63 46.96 1.40**
Barriers to care total (0–10)a 1.64 (2.18) 0.95 (1.42) 0.84*** 1.73 (2.25) 1.64 (2.17) 0.99
HIV testing access (0–4)a 3.32 (0.58) 3.60 (0.47) 1.75*** 3.23 (0.60) 3.50 (0.49) 1.65***
aOdds ratios for these variables reflect the expected change in odds of recent testing for a 1 SD increase in the variable.
*p < 0.05.
**p < 0.01.
***p < 0.001.
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Table  3 shows adjusted associations between testing for 
HIV in the past year and other variables. Among women, 
lifetime STI testing [adjusted odds ratio (AOR)  =  1.99] and 
diagnosis (AOR = 2.21), peer norms in support of HIV testing 
(AOR = 1.22), better access to medical care (AOR = 1.57), better 
access to HIV testing (AOR = 1.48), and running out of money 
for basic necessities in the past year (AOR =  1.53) were each 
positively associated with testing for HIV in the past year. An 
alcohol or drug problem also was positively associated with test-
ing for HIV in the past year (AOR = 1.35) but with only marginal 
statistical significance. Drug use frequency in the past 30 days 
was negatively associated with testing for HIV in the past year 
(AOR = 0.81). Among men, lifetime STI testing (AOR = 1.46) 
and diagnosis (AOR = 2.08), peer norms in support of HIV test-
ing (AOR = 1.23), better access to HIV testing (AOR = 1.52), 
and lifetime substance use treatment (AOR =  1.66) were each 
positively associated with testing for HIV in the past year. Also, 
both men who were never incarcerated (AOR  =  1.60) and 
men who were incarcerated within the past year (AOR = 1.74) 
were more likely to have tested for HIV in the past year when 
TaBle 3 | Factors associated with recent hiV testing among female and male heterosexuals at high risk in new York city: multivariate logistic 
regression.
Female Male
aOr 95% ci p-value aOr 95% ci p-value
Sexually transmitted infections
Tested, never diagnosed, vs. never tested 1.99 (1.34–2.98) 0.0008 1.46 (1.06–2.02) 0.0199
Tested, diagnosed, vs. never tested 2.21 (1.53–3.21) <0.0001 2.08 (1.57–2.76) <0.0001
HIV testing peer normsa 1.22 (1.05–1.43) 0.0114 1.23 (1.08–1.41) 0.0018
HIV testing accessa 1.48 (1.25–1.77) <0.0001 1.52 (1.33–1.75) <0.0001
Able to get medical care when needed 1.57 (1.16–2.11) 0.0030
Ran out of money for basic necessities past 12 months 1.53 (1.09–2.16) 0.0151
Drug use frequency past 30 days 0.81 (0.69–0.95) 0.0116
Alcohol or drug problem 1.35 (0.98–1.87) 0.0703
Incarceration
Never vs. lifetime but not past 12 months 1.60 (1.16–2.22) 0.0040
Past 12 months vs. lifetime but not past 12 months 1.74 (1.31–2.31) 0.0002
Ever in substance use treatment 1.66 (1.28–2.15) 0.0001
aAdjusted odds ratios for these variables reflect the expected change in odds of recent testing for a 1 SD increase in the variable.
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compared to men who reported lifetime incarceration but had 
not been incarcerated in the past year.
Because lifetime STI testing had the strongest unique associa-
tion with recent HIV testing in the multivariable models for both 
female and male participants, and because STI testing may be 
related to a number of the other variables considered as potential 
determinants of HIV testing, we excluded lifetime STI testing 
as a sensitivity analysis for the results presented in Table 3. For 
females, excluding lifetime STI testing allowed HIV knowledge 
to enter the final multivariable model. HIV knowledge was posi-
tively associated with recent HIV testing (AOR = 1.24, 95% CI: 
1.06–1.46, p = 0.0081). For males, excluding lifetime STI testing 
did not lead to any other changes to the variables included in 
the final multivariable model presented in Table 3.
DiscUssiOn
This study advances what is known about HIV testing patterns 
among an under-studied population of adults at high risk for 
HIV in the US – heterosexuals who reside in urban HRAs with 
elevated poverty and HIV prevalence rates. Participants in this 
sample evidenced numerous serious risk factors for HIV infec-
tion and other adverse psychosocial outcomes, such as high rates 
of unemployment, homelessness, incarceration, and substantial 
rates of substance use problems, as well as protective factors. For 
example, almost all had health insurance and half were married 
or in long-term stable relationships, suggesting the availability of 
social support. We found half of those enrolled had been tested 
for HIV in the past year, and 37% evidenced regular, annual HIV 
testing. While these HIV testing rates do not yet meet the CDC’s 
goals of universal or near universal coverage, they are substan-
tially higher than a recent local NHBS study with HHR that used 
the same sampling method and an equivalent definition of the 
population, where approximately a third had received past-year 
HIV testing (10). In light of national and local policies and HIV 
testing initiatives put in place to increase HIV testing among 
those at risk, including the routinizing HIV testing, study findings 
may therefore reflect upward trends in annual HIV testing rates 
among HHR (54, 55). (Alternately, they may reflect methodo-
logical differences between the present study and NHBS.) Yet, 
despite these gains, most HHR do not test annually, and they 
are substantially less likely to be tested annually than their MSM 
peers. In fact, a recent NHBS study of MSM recruited in New 
York City found about three quarters (76%) had tested within 
the past year (4), highlighting the importance of understanding 
factors that promote or impede HIV testing among HHR.
sociodemographic, Background, and 
health-related Factors
Among women, the frequency of drug use reduced the odds 
of past-year HIV testing. Drug use often results in “competing 
priorities,” which thereby reduce engagement in health-care 
behavior and also creates experiences of stigma for the drug user 
(56). Stigma operates by raising the specter of serious potential 
consequences associated with the socially undesirable behavior 
or condition, including rejection by friends and family, loss of 
a job or housing, discrimination, and violence (57). For female 
HHR who use drugs, who may also be represented in other 
stigmatized categories (e.g., poor, formerly incarcerated), the 
psychosocial barriers to HIV testing, including the possibility of 
being included in an additional stigmatized social category, may 
therefore be serious. Yet the consequences of late HIV diagnosis 
are grave, for individuals, their sexual partners, and their com-
munities. Thus, to reduce the effect of drug use as a barrier to HIV 
testing for female HHR, multiple, simultaneous strategies are 
needed, some of which are already in place and others of which 
exist and could theoretically be implemented on a larger scale. 
These strategies include the normalization and routinization of 
HIV testing in health-care settings that serve women; providing 
testing in trusted community-based venues such as faith-based 
settings; anonymous HIV testing; home-based self-testing; poli-
cies and programs to reduce drug, HIV, and related stigmas; and 
providing harm reduction-based services to assist women to 
better manage substance use in order to reduce impediments to 
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HIV testing (58, 59). The present study did not find recent drug 
use was a barrier to HIV testing for men, but their engagement 
in substance use treatment was associated with past-year HIV 
testing. There is good evidence that drug use affects men and 
women differently (60), and more research is needed to identify 
the gender-specific pathways from drug use to drug treatment 
to HIV testing and how the adverse effects of drug use can be 
ameliorated for both men and women.
individual/attitudinal Barriers  
to hiV Testing
Women who ran out of money for basic necessities in the past 
year were more likely to have been tested for HIV, an unexpected 
finding. We speculate that those with serious financial hardship 
may have greater need for social services, which in turn leads them 
to settings where HIV testing is offered. Alternatively, serious 
deprivation may trigger survival-related behaviors and increased 
perceived risk of HIV, thereby motivating HIV testing (18). In 
a sensitivity analysis that excluded lifetime STI testing, general 
knowledge of HIV was associated with past-year testing in women 
but not men. A recent systematic review of psychological factors 
related to HIV testing similarly found a positive association, albeit 
small, between HIV knowledge and HIV testing (18), although 
it did not examine gender differences. Thus, while the present 
study highlights the importance of addressable, individual-level 
factors in HIV testing behavior such as HIV knowledge, taken 
together with the literature, it also underscores the complexity of 
health behavior, particularly among populations at-risk, and the 
need to examine the pathways to HIV testing separately for men 
and women.
social Factors and hiV Testing
Peer norms regarding HIV testing, that is the extent to which 
participants perceived their peers as supporting HIV testing for 
themselves, and with respect to the participant, were associated 
with HIV testing for males and females. This highlights the criti-
cal role perceptions of peers’ attitudes and actions have on one’s 
own behavior (25). Past studies have found unfavorable social 
norms about HIV are closely aligned to perceived HIV stigma 
(61). Indeed, although not directly examined in the present 
study, stigma continues to be a potent barrier to HIV testing 
and treatment, as detailed by Mahajan and colleagues in a recent 
review (62) and discussed above. Yet these authors note that our 
understanding of the role of stigma in HIV/AIDS is hampered 
by the absence of an explicit conceptualization, a comprehensive 
framework that includes a structural understanding of stigma 
and valid measures (62). Our research on HHR that takes struc-
tural and related emotional/attitudinal factors, such as fear and 
mistrust, into account is well suited to advance the literature on 
stigma, which will be explored in future studies.
structural Factors and access  
to hiV Testing
Sexually transmitted infection testing can be considered a 
background factor, but such testing is embedded in health-care 
systems, and therefore, we consider the relationships among STI 
and HIV testing and access to medical settings together in this 
section. For both males and females, receiving testing for STIs 
over the lifetime, whether or not a diagnosis was confirmed, was 
associated with past-year HIV testing, as was their having been 
diagnosed with an STI in the past. We hypothesize that individu-
als concerned about STIs, for example, after engaging in behavior 
they considered risky, or experiencing symptoms of infection, 
present for STI testing in a setting where HIV testing is offered as 
well (63). Thus, this moment of heightened risk or perceived risk 
may motivate the acceptance of HIV testing, and also create the 
conditions for future HIV testing (64). Moreover, STIs, perhaps 
with the exception of HSV-2, tend to be less stigmatizing than 
HIV, which may encourage HHR to seek out STI testing in these 
types of circumstances (65), highlighting the important role of 
STI testing in achieving the goal of HIV elimination (66). Yet 
at present, the STI and HIV prevention systems in the US are 
considered “siloed” or largely separate, which may lead to missed 
opportunities for comprehensive sexual health services (67). In 
fact, public health system leaders in the US have called for better 
integration of STI and HIV services to improve the early diag-
nosis of a range of sexually transmitted health problems (63). 
Further, it is possible HIV testing triggered STI testing in some 
cases (68), and the cross-sectional nature of the data do not allow 
us to establish temporal order in this association.
Having tested in the past year was associated with involve-
ment in medical and other systems (e.g., criminal justice and 
substance use treatment) where HIV testing is typically offered, 
but these associations varied by gender. The ability to access 
general medical care promoted recent HIV testing among 
females but not males, perhaps reflecting women’s regular 
engagement in gynecological and prenatal care, where HIV 
testing is normalized and routinely offered (1), and/or social 
norms regarding the need for regular gynecological health care 
among women (69). Among men, engagement in substance use 
treatment was associated with HIV testing. Indeed, these treat-
ment settings may offer HIV testing on-site (70) and/or foster 
motivation for HIV testing (71). Further, receiving substance 
use treatment may comprise a type of structural intervention 
reducing other “competing priorities” while enhancing access 
to HIV testing. Men who had been incarcerated in their lives, 
but not in the past year, were less likely to have received past-
year HIV testing, highlighting the ways in which incarceration 
both impedes HIV testing, for example, when past incarceration 
serves as a barrier to HIV testing access (72) or boosts HIV 
testing rates (for example, when men are tested in that setting) 
(73). On the other hand, most HHR will not encounter sub-
stance use treatment and criminal justice systems as regularly 
as health-care settings. Therefore, these systems alone are not 
sufficient to achieve sufficient provision of regular, annual HIV 
testing for HHR.
limitations
One limitation was the study’s cross-sectional design, which 
restricts causal inference. Further, additional unmeasured 
variables may be associated with HIV testing in this population, 
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such as stigma, which was not assessed in this study but which 
is an important factor, as described above. The data are based 
on the quality of the RDS sampling approach described above, 
which may have missed key subpopulations of HHR that were 
not recruited by peers or who had a small probability of being 
recruited. This includes persons who decline to participate 
in HIV testing-related research studies because of distrust of 
research, fear of HIV testing, or HIV stigma. Finally, there may 
have been issues related to recall and social desirability biases in 
the reporting of HIV testing.
implications
Heterosexuals at high risk experience serious and multifaceted 
barriers to regular, annual HIV testing that vary to some extent by 
gender. The present study suggests a number of approaches that, 
taken together, have potential to address this gap. These include 
increasing the number and types of systems both male and female 
HHR encounter that offer high-quality HIV testing, with an 
emphasis on providing easy access to HIV testing, and developing 
culturally appropriate strategies to enhance readiness and moti-
vation to test for HIV; insuring that CDC guidelines regarding 
annual HIV testing are widely known among HHR; promoting 
STI as well as HIV testing and better integrating these two largely 
separate systems; delivering active outreach, support, and tailored 
services for women who use drugs; and increasing general HIV 
knowledge to foster acceptance of HIV testing, particularly for 
women. Further, the present study highlights the potential utility 
of social/behavioral intervention approaches such as peer-driven 
intervention, which can be used to harness the positive influence 
of social networks in order to reduce unfavorable shared peer 
norms regarding HIV testing and thereby increase motivation 
for HIV testing (74, 75). Further, future research on policies and 
interventions to reduce stigma is recommended, as stigma is a 
critical impediment to regular, annual HIV testing among HHR 
(18), but effective strategies to reduce stigma have received insuf-
ficient attention in the literature to date.
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